Antagonistic interaction between TTA-A2 and paclitaxel for anti-cancer effects by complex formation with T-type calcium channel

Kumari, Neema and Dalal, Vikram and Kumar, Pravindra and Rath, Subha Narayan (2020) Antagonistic interaction between TTA-A2 and paclitaxel for anti-cancer effects by complex formation with T-type calcium channel. Journal of Biomolecular Structure and Dynamics. pp. 1-12. ISSN 0739-1102

Full text not available from this repository. (Request a copy)

Abstract

Studies have shown that in cancer cells, there is an increased T-type calcium channel (TTCC) expression compared to healthy cells. Therefore, the studies targeting TTCC for cancer therapy have shown many positive outcomes. Here, we have used TTA-A2- a potent TTCC inhibitor as a test drug, and paclitaxel (PTX)- a tubule-binding anti-cancer agent as a positive control. Blocking TTCC has shown to overcome resistance in cancer cells towards anti-cancer drugs by reducing calcium influx, and some studies have shown that PTX treatment also reduces the intracellular calcium signaling in cells. So, there is a possibility that PTX might be interacting with calcium channels. Since, drug-drug interaction can cause severe side-effects, or alter the actions of each other; we aim to study the interactions among TTA-A2, PTX, and TTCC. In this study, we have used computational analysis to test the binding of TTA-A2 and PTX with TTCC. To confirm the in-silico result, we further tested these drugs in a 3D spheroid model of A549, a lung adenocarcinoma cell line. The in-silico result showed that both the drugs, TTA-A2 and PTX, could interact at the same site of TTCC to form a higher stable complex as compared to the TTCC-native. The in vitro result showed the antagonistic interaction between the drugs when they are used at the same time. By using the sequential treatment, the spheroids were sensitized by TTA-A2, before treating with PTX. The result indicated that sequential treatment could help to overcome the antagonistic interaction between the two drugs. Communicated by Ramaswamy H. Sarma.

[error in script]
IITH Creators:
IITH CreatorsORCiD
Kumari, NeemaUNSPECIFIED
Rath, Subha NarayanUNSPECIFIED
Item Type: Article
Uncontrolled Keywords: A549; Lung cancer; paclitaxel; synergistic/antagonistic effect; T-type calcium channel; TTA-A2
Subjects: Biomedical Engineering
Divisions: Department of Biomedical Engineering
Depositing User: . LibTrainee 2021
Date Deposited: 31 Jul 2021 04:22
Last Modified: 31 Jul 2021 04:22
URI: http://raiithold.iith.ac.in/id/eprint/8583
Publisher URL: http://doi.org/10.1080/07391102.2020.1839558
OA policy: https://v2.sherpa.ac.uk/id/publication/23484
Related URLs:

Actions (login required)

View Item View Item
Statistics for RAIITH ePrint 8583 Statistics for this ePrint Item